4
Changes in Ownership
KYNTRA BIO, INC. Filed Acc 0001415889-25-001310
Options or other derivatives
- CEO acquired 1,300,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Wettig Thane CEO | 2025-01-09 | Grant or award · Stock Option (Right to Buy) | +1,300,000 | 1,300,000 | D: show line 1 in the form |
Loading xslF345X05/form4-01102025_110107.xml…